ClinicalTrials.govpublic full text
Nivolumab in Children and Adults With Nasopharyngeal Carcinoma
nasopharyngeal carcinoma, nasopharyngeal cancer, nasopharyngeal neoplasms, nasopharynx cancer, immunotherapy, nivolumab, children, adults, chemotherapy, immune checkpoint inhibitor, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 893983
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.